Cao Jianhong, McNevin John, Holte Sarah, Fink Lisa, Corey Lawrence, McElrath M Juliana
Program in Infectious Diseases, Clinical Research Division, Fred Hutchinson Cancer Research Center and Department of Medicine, University of Washington, Seattle, Washington 98109, USA.
J Virol. 2003 Jun;77(12):6867-78. doi: 10.1128/jvi.77.12.6867-6878.2003.
Human immunodeficiency virus type 1 (HIV-1)-specific CD8(+) T cells provide an important defense in controlling HIV-1 replication, particularly following acquisition of infection. To delineate the breadth and potency of these responses in patients upon initial presentation and before treatment, we determined the fine specificities and frequencies of gamma interferon (IFN-gamma)-secreting CD8(+) T cells recognizing all HIV-1 proteins in patients with primary infection. In these subjects, the earliest detected responses were directed predominantly against Nef, Tat, Vpr, and Env. Tat- and Vpr-specific CD8(+) T cells accounted for the greatest frequencies of mean IFN-gamma spot-forming cells (SFC). Nef-specific responses (10 of 21) were more commonly detected. A mean of 2.3 epitopes were recognized with various avidities per subject, and the number increased with the duration of infection (R = 0.47, P = 0.031). The mean frequency of CD8(+) T cells (985 SFC/10(6) peripheral blood mononuclear cells) correlated with the number of epitopes recognized (R = 0.84, P < 0.0001) and the number of HLA-restricting alleles (R = 0.79, P < 0.0001). Neither the total SFC frequencies nor the number of epitopes recognized correlated with the concurrent plasma viral load. Seventeen novel epitopes were identified, four of which were restricted to HLA alleles (A23 and B72) that are common among African descendents. Thus, primary HIV-1 infection induces strong CD8(+)-T-cell immunity whose specificities broaden over time, but their frequencies and breadth do not correlate with HIV-1 containment when examined concurrently. Many novel epitopes, particularly directed to Nef, Tat, and Env, and frequently with unique HLA restrictions, merit further consideration in vaccine design.
1型人类免疫缺陷病毒(HIV-1)特异性CD8(+) T细胞在控制HIV-1复制方面发挥着重要防御作用,尤其是在感染初期。为了明确初次就诊且未接受治疗的患者中这些反应的广度和强度,我们测定了原发性感染患者中识别所有HIV-1蛋白的分泌γ干扰素(IFN-γ)的CD8(+) T细胞的精细特异性和频率。在这些受试者中,最早检测到的反应主要针对Nef、Tat、Vpr和Env。Tat和Vpr特异性CD8(+) T细胞在平均IFN-γ斑点形成细胞(SFC)中占比最高。Nef特异性反应(21例中有10例)更常被检测到。每位受试者平均识别出2.3个具有不同亲和力的表位,且表位数量随感染持续时间增加(R = 0.47,P = 0.031)。CD8(+) T细胞的平均频率(985 SFC/10(6)外周血单个核细胞)与识别的表位数量(R = 0.84,P < 0.0001)以及HLA限制性等位基因数量(R = 0.79,P < 0.0001)相关。总SFC频率和识别的表位数量均与同期血浆病毒载量无关。鉴定出17个新表位,其中4个仅限于非洲裔中常见的HLA等位基因(A23和B72)。因此,原发性HIV-1感染可诱导强烈的CD8(+) T细胞免疫,其特异性随时间推移而拓宽,但同时检测时其频率和广度与HIV-1抑制无关。许多新表位,特别是针对Nef、Tat和Env的表位,且通常具有独特的HLA限制性,在疫苗设计中值得进一步考虑。